The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Prevalence of Creatinine Phosphokinase Increase in Patients With Solid Tumors Treated by Inhibitors of Tyrosine Kinases
Official Title: National Study of Prevalence of Creatinine Phosphokinase (CPK) Increase in Patients With Solid Tumors Treated by Inhibitors of Tyrosine Kinases (TKI)
Study ID: NCT01248429
Brief Summary: This study describes the elevation of CPK in patient treated for solid tumors by TKI
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Centre Paul Papin, Angers, , France
Hôpital Jean Minjoz, Besancon, , France
CHU Bordeaux, Bordeaux, , France
Institut Bergonié, Bordeaux, , France
Centre François Baclesse, Caen, , France
Centre Jean Perrin, Clermont Ferrand, , France
Hôpital Henri Mondor - APHP, Creteil, , France
Centre Oscar Lambret, Lille, , France
CHU Limoges, Limoges, , France
Hôpital Edouard Herriot, Lyon, , France
Centre Léon Bérard, Lyon, , France
Institut Paoli Calmettes, Marseille, , France
Centre Val d'Aurelle, Montpellier, , France
Centre Antoine Lacassagne, Nice, , France
Hôpital Saint-Louis - APHP, Paris, , France
Hôpital Cochin - APHP, Paris, , France
Hôpital Tenon - APHP, Paris, , France
Institut Curie, Paris, , France
Institut Jean Godinot, Reims, , France
CHU Robert Debré, Reims, , France
Centre Eugène Marquis, Rennes, , France
Centre Henri Becquerel, Rouen, , France
Centre René Huguenin, Saint Cloud, , France
Institut de Cancérologie de la Loire, Saint Priest en Jarez, , France
Institut Claudius Régaud, Toulouse, , France
Centre Alexis Vautrin, Vandoeuvre Les Nancy, , France
Institut Gustave Roussy, Villejuif, , France
Name: Antoine ADENIS, MD, PhD
Affiliation: Centre Oscar Lambret
Role: PRINCIPAL_INVESTIGATOR